LuanP.V., TienN.D., HaiN.M., DuyenT.T. and ThanhB.T. 2021. The results of gefitinib as a first-line therapy in elderly patients with advanced non-small cell lung cancer with EGFR mutations. Tạp chí Y Dược lâm sàng 108. 16, 6 (Sep. 2021). DOI:https://doi.org/10.52389/ydls.v16i6.836.